Updates and Advances in Platelet Rich Plasma and Biocellular Prolotherapy

Donna Alderman, D.O. Medical Director, Hemwall Center for Orthopedic Regenerative Medicine Co-Director, Institute for Biocellular Regenerative Medicine

American Osteopathic Association of Prolotherapy Regenerative Medicine, Conference May 2013

Overview of Lecture
1. Brief Overview of PRP 2. Is PRP Prolotherapy a Placebo? Video 3. Not all PRP is the same.
Concentration? Activation? RBCs, WBC s?

4. Importance of clarity when describing PRP 5. Update on PRP studies and World Anti-Doping Agency 6. Overview of Biocellular Prolotherapy
What it is, when to use it Nomenclature

7. Alderman-Alexander Protocol sequence: Video 8. Conclusion 9. Questions